Clinical Trial Update: NAC Inhalation in the Treatment Of Symptomatic acuTe rhinosinUSitis

View source ↗

Summary

Clinical trial evaluating inhaled N-acetylcysteine for symptomatic acute rhinosinusitis has completed, with results posted on February 20, 2024. Sponsor: Boryun…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis

Drugs mentioned

• N-acetylcysteine inhalation (N-acetylcysteine inhalation)

Snippet

Sponsor: Boryung Pharmaceutical Co., Ltd | Conditions: Acute Rhinosinusitis, Recurrent Acute Rhinosinusitis | Status: COMPLETED | Results posted: 2024-02-20